Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H17N3O2.ClH |
| Molecular Weight | 283.754 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCCC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
InChI
InChIKey=KQIVUXJJSRFRFM-UHFFFAOYSA-N
InChI=1S/C13H17N3O2.ClH/c1-3-4-5-9-6-7-10-11(8-9)15-12(14-10)16-13(17)18-2;/h6-8H,3-5H2,1-2H3,(H2,14,15,16,17);1H
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Parbendazole. | 2010 |
|
| Epidemiological aspects of the first outbreak of Baylisascaris procyonis larva migrans in rabbits in Japan. | 2003-04 |
|
| In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives. | 1997-12 |
|
| Activity of benzimidazoles against cryptosporidiosis in neonatal BALB/c mice. | 1995-10 |
|
| In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles. | 1994-02 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
83601-81-4
Created by
admin on Mon Mar 31 21:58:32 GMT 2025 , Edited by admin on Mon Mar 31 21:58:32 GMT 2025
|
PRIMARY | |||
|
76210635
Created by
admin on Mon Mar 31 21:58:32 GMT 2025 , Edited by admin on Mon Mar 31 21:58:32 GMT 2025
|
PRIMARY | |||
|
DTXSID80109166
Created by
admin on Mon Mar 31 21:58:32 GMT 2025 , Edited by admin on Mon Mar 31 21:58:32 GMT 2025
|
PRIMARY | |||
|
YV5RTO20GO
Created by
admin on Mon Mar 31 21:58:32 GMT 2025 , Edited by admin on Mon Mar 31 21:58:32 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
